1.
Veltkamp M, Drent M, Baughman RP. Infliximab or biosimilars in sarcoidosis; to switch or not to switch?. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2016 Jan. 15 [cited 2023 Feb. 7];32(4):280-3. Available from: https://www.mattioli1885journals.com/index.php/sarcoidosis/article/view/5001